United Kingdom (UK) Microrna Market (2025-2031) | Forecast, Competitive Landscape, Size & Revenue, Industry, Analysis, Growth, Share, Companies, Outlook, Trends, Value, Segmentation

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Microrna Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Microrna Market - Industry Life Cycle

3.4 United Kingdom (UK) Microrna Market - Porter's Five Forces

3.5 United Kingdom (UK) Microrna Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 United Kingdom (UK) Microrna Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 United Kingdom (UK) Microrna Market Revenues & Volume Share, By End-use, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic diseases in the UK leading to a higher demand for molecular diagnostics including miRNA testing.

4.2.2 Growing investments in research and development in the field of microRNA for therapeutic applications.

4.2.3 Technological advancements in microRNA detection and analysis techniques driving market growth.

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for miRNA-based products in the UK may pose challenges for market entry and product approval.

4.3.2 Limited awareness and adoption of microRNA testing among healthcare professionals and patients in the UK.

6.1 United Kingdom (UK) Microrna Market, By Type

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Microrna Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 United Kingdom (UK) Microrna Market Revenues & Volume, By Isolation, 2021- 2031F

6.1.4 United Kingdom (UK) Microrna Market Revenues & Volume, By miRNA cDNA Synthesis, 2021- 2031F

6.1.5 United Kingdom (UK) Microrna Market Revenues & Volume, By Functional Analysis, 2021- 2031F

6.1.6 United Kingdom (UK) Microrna Market Revenues & Volume, By Others, 2021- 2031F

6.2 United Kingdom (UK) Microrna Market, By Application

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Microrna Market Revenues & Volume, By Cancer, 2021- 2031F

6.2.3 United Kingdom (UK) Microrna Market Revenues & Volume, By Infectious Diseases, 2021- 2031F

6.2.4 United Kingdom (UK) Microrna Market Revenues & Volume, By Immunological Disorder, 2021- 2031F

6.2.5 United Kingdom (UK) Microrna Market Revenues & Volume, By Cardiovascular Disease, 2021- 2031F

6.2.6 United Kingdom (UK) Microrna Market Revenues & Volume, By Neurological Disease, 2021- 2031F

6.2.7 United Kingdom (UK) Microrna Market Revenues & Volume, By Others, 2021- 2031F

6.3 United Kingdom (UK) Microrna Market, By End-use

6.3.1 Overview and Analysis

6.3.2 United Kingdom (UK) Microrna Market Revenues & Volume, By Biotechnology & Pharmaceutical Companies, 2021- 2031F

6.3.3 United Kingdom (UK) Microrna Market Revenues & Volume, By Academic & Government Research Institutes, 2021- 2031F

6.3.4 United Kingdom (UK) Microrna Market Revenues & Volume, By Others, 2021- 2031F

7.1 United Kingdom (UK) Microrna Market Export to Major Countries

7.2 United Kingdom (UK) Microrna Market Imports from Major Countries

8.1 Number of research publications on microRNA in the UK indicating the level of scientific activity and interest in the field.

8.2 Funding allocated to microRNA research projects by government agencies or private investors.

8.3 Number of clinical trials involving microRNA-based diagnostics or therapeutics conducted in the UK, reflecting the market's progress and potential for growth.

8.4 Adoption rate of microRNA testing technologies in clinical settings or research laboratories in the UK.

9.1 United Kingdom (UK) Microrna Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 United Kingdom (UK) Microrna Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 United Kingdom (UK) Microrna Market Opportunity Assessment, By End-use, 2021 & 2031F

10.1 United Kingdom (UK) Microrna Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Microrna Market Competitive Benchmarking, By Operating and Technical Parameters